C96.4Sarcoma of dendritic cells (accessory cells)
Code usage status
Primary diagnosis
May be used as the primary diagnosis
Apply only when it matches the confirmed diagnosis and the documented clinical record.
Specificity
Complete code in the classification
Use when the diagnosis matches and no exclusion applies.
- Chapter II
- Neoplasms
- Group C00-C97
- Malignant neoplasms U ác tính
- Official Vietnamese name
- U ác tính [sarcoma] tế bào đuôi gai (tế bào phụ)
- Additional WHO coding guidance
- Interdigiating dendritic cell sarcoma Langerhans-cell sarcoma Sarcoma of follicular dendritic cells
Related C96 codes
C96
Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
C96.0
Primary diagnosis candidate
Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis [Letterer-Siwe disease]
C96.2
Primary diagnosis candidate
Malignant mast cell tumour
C96.5
Primary diagnosis candidate
Multifocal and unisystemic Langerhans-cell histiocytosis
C96.6
Primary diagnosis candidate
Unifocal Langerhans-cell histiocytosis
C96.7
Primary diagnosis candidate
Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
C96.9
Primary diagnosis candidate
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
Clinical record checklist
View coding guide →- Confirm that the code matches the final documented diagnosis.
- Use one primary-diagnosis code and record only relevant additional conditions.
- Review Ministry indicators, inclusions, exclusions and notes.
- Do not infer a diagnosis beyond the clinical record.
2026 regulatory basis
Indicators are taken from columns 24–29 of the classification accompanying Circular 06/2026/TT-BYT, cross-referenced with Decision 1849/QĐ-BYT and Official Dispatch 4059/BYT-BH.
